Literature DB >> 25560405

Impact of nonaspirin nonsteroidal anti-inflammatory agents and acetaminophen on sensorineural hearing loss: a systematic review.

Meghann E Kyle1, James C Wang2, Jennifer J Shin3.   

Abstract

OBJECTIVE: To perform a systematic review evaluating the association between sensorineural hearing loss and (1) nonsteroidal anti-inflammatory drugs (NSAIDs) as a class, (2) NSAIDs available over the counter, (3) NSAIDs in short intravenous courses, (4) prescription NSAIDs utilized by patients without systemic inflammatory conditions, (5) prescription NSAIDs in patients with arthritides, and (6) acetaminophen with and without concomitant narcotic usage. DATA SOURCES: Computerized searches of PubMed, EMBASE, and the Cochrane Library were updated through May 2014, along with manual searches and inquiries to topic experts. REVIEW
METHODS: The systematic review was performed according to an a priori protocol. Data extraction was performed by 2 independent investigators, and it focused on relevant audiologic measurements, methodological elements related to risk of bias, and potential confounders.
RESULTS: The 23 criterion-meeting studies included a total of 92,532 participants, with mixed results. Sulindac was the only specific agent to have been studied with formal audiometry in a randomized double-blind placebo-controlled trial in which hearing was the reported primary outcome: Although an effect was seen in the unadjusted analysis (pure tone threshold>15 dB, 9.3% vs 2.9%; relative risk [RR], 3.2; confidence interval [CI], 1.09-9.55; P=.02), the effect dissipated in the adjusted analysis (P=.09). There was a significant effect on self-reported hearing loss from NSAIDs as a class (RR, 1.21; CI, 1.11-1.33), ibuprofen (RR, 1.13; CI, 1.06-1.19), and acetaminophen (RR, 1.21; CI, 1.11-1.33), but no formal audiometric data confirm or refute this suggested effect. Audiometry has demonstrated profound loss in some instances of acetaminophen-narcotic combination ingestions.
CONCLUSIONS: Data are varied regarding the impact of NSAIDs and acetaminophen on population hearing health. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  acetaminophen; diflunisal; fenoprofen; hearing loss; ibuprofen; indomethacin; ketorolac; naproxen; nonsteroidal anti-inflammatory drugs; piroxicam; pirprofen; sulindac

Mesh:

Substances:

Year:  2015        PMID: 25560405      PMCID: PMC4465569          DOI: 10.1177/0194599814564533

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  63 in total

1.  Deafness associated with abuse of hydrocodone/acetaminophen.

Authors:  A K Oh; A Ishiyama; R W Baloh
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

2.  Prophylactic use of NSAIDs by athletes: a risk/benefit assessment.

Authors:  Stuart J Warden
Journal:  Phys Sportsmed       Date:  2010-04       Impact factor: 2.241

3.  Evidence-based medicine in otolaryngology, part 1: the multiple faces of evidence-based medicine.

Authors:  Jennifer J Shin; Gregory W Randolph; Steven D Rauch
Journal:  Otolaryngol Head Neck Surg       Date:  2010-05       Impact factor: 3.497

4.  Validation of the use of self-reported hearing loss and the Hearing Handicap Inventory for elderly among rural Indian elderly population.

Authors:  R Deepthi; Arvind Kasthuri
Journal:  Arch Gerontol Geriatr       Date:  2012-08-13       Impact factor: 3.250

5.  Pirprofen and aspirin in the treatment of rheumatoid arthritis.

Authors:  J D Davis; A G Struth; R A Turner; E J Pisko; I R Ruchte
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

6.  Over-the-counter medication use among US preschool-age children.

Authors:  M D Kogan; G Pappas; S M Yu; M Kotelchuck
Journal:  JAMA       Date:  1994-10-05       Impact factor: 56.272

Review 7.  Hearing loss in older adults.

Authors:  Anne D Walling; Gretchen M Dickson
Journal:  Am Fam Physician       Date:  2012-06-15       Impact factor: 3.292

8.  Impact of oral versus intravenous ibuprofen on neurodevelopmental outcome: a randomized controlled parallel study.

Authors:  Zeynep Eras; Tulin Gokmen; Omer Erdeve; Banu Mutlu Ozyurt; Bagdagul Saridas; Ugur Dilmen
Journal:  Am J Perinatol       Date:  2013-01-28       Impact factor: 1.862

9.  Aspirin-induced hearing loss as a model of sensorineural hearing loss.

Authors:  D McFadden; H S Plattsmier; E G Pasanen
Journal:  Hear Res       Date:  1984-12       Impact factor: 3.208

10.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Authors:  Britton Trabert; Roberta B Ness; Wei-Hsuan Lo-Ciganic; Megan A Murphy; Ellen L Goode; Elizabeth M Poole; Louise A Brinton; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Galina Lurie; Susanne K Kjær; Estrid Hogdall; Allan Jensen; Daniel W Cramer; Kathryn L Terry; Allison Vitonis; Elisa V Bandera; Sara Olson; Melony G King; Urmila Chandran; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste Leigh Pearce; Malcolm C Pike; Andrew Berchuck; Joellen M Schildkraut; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 11.816

View more
  5 in total

1.  Expression of drug metabolizing enzymes and transporters in the cochlea: Implications for drug delivery and ototoxicity.

Authors:  Stefanie Kennon-McGill; Melissa M Clemens; Mitchell R McGill
Journal:  Hear Res       Date:  2019-05-15       Impact factor: 3.208

Review 2.  [The professional ear user-implications for the prevention, diagnosis, and treatment of ear diseases].

Authors:  David Bächinger; Raphael Jecker; Jean-Christoph Hannig; Andreas Werner; Horst Hildebrandt; Michael Eidenbenz; Martin Kompis; Tobias Kleinjung; Dorothe Veraguth
Journal:  HNO       Date:  2022-10-21       Impact factor: 1.330

3.  Sensorineural deafness following routine transurethral resection of the prostate.

Authors:  Benjamin Bowsher
Journal:  BMJ Case Rep       Date:  2015-11-12

4.  Does an Otolaryngology-Specific Database Have Added Value? A Comparative Feasibility Analysis.

Authors:  Angela M Bellmunt; Rhonda Roberts; Walter T Lee; Kris Schulz; Melissa A Pynnonen; Matthew G Crowson; David Witsell; Kourosh Parham; Alan Langman; Andrea Vambutas; Sheila E Ryan; Jennifer J Shin
Journal:  Otolaryngol Head Neck Surg       Date:  2016-07       Impact factor: 3.497

5.  The DNA methylation inhibitor RG108 protects against noise-induced hearing loss.

Authors:  Zhiwei Zheng; Shan Zeng; Chang Liu; Wen Li; Liping Zhao; Chengfu Cai; Guohui Nie; Yingzi He
Journal:  Cell Biol Toxicol       Date:  2021-03-15       Impact factor: 6.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.